Analysed METAVIA INC (MTVA:NASDAQ) News Sources
MetaVia to Present Obesity Data at the American Diabetes Association's (ADA) 2026 Scientific Sessions
18-05-2026
yahoo.com
MetaVia Highlights Peer-Reviewed Publication Supporting the Anti-Fibrotic Potential of Vanoglipel in MASH
20-05-2026
yahoo.com
MetaVia Presents Higher-Dose Phase 1 Results for DA-1726 at EASL Congress 2026, Supporting Potential in Obesity and MASH
27-05-2026
yahoo.com
MTVA: No Evidence for Changes in Cardiovascular Parameters in Phase 1 Trial of DA-1726
28-05-2026
yahoo.com
MetaVia Presents New Late-Breaking Obesity and Metabolic Data at the ADA 2026 Scientific Sessions Supporting DA-1726 Differentiation and Vanoglipel Combination Potential
08-06-2026
yahoo.com
OTC Markets Life Sciences Investor Forum: MetaVia CEO HH Kim and CFO Marshall Woodworth with Zacks SCR's David Bautz
30-06-2026
yahoo.com
MetaVia Announces Completion of Dose Titration in Phase 1 Part 3 Study of DA-1726 for the Treatment of Obesity
09-07-2026
yahoo.com
MetaVia Reports Second Quarter 2026 Financial Results and Provides Corporate Update
06-08-2026
yahoo.com
What is the current price of METAVIA INC (MTVA:NASDAQ)?
The current price of METAVIA INC (MTVA:NASDAQ) is $1.68.
METAVIA INC (MTVA:NASDAQ) absolute price change since previous trading day?
The absolute price change of METAVIA INC (MTVA:NASDAQ) since the previous trading day is $0.04.
METAVIA INC (MTVA:NASDAQ) percentage price change since previous trading day?
The percentage price change of METAVIA INC (MTVA:NASDAQ) since the previous trading day is 2.439%.
What is the most recent average sentiment score for METAVIA INC (MTVA:NASDAQ)?
The most recent average sentiment score for METAVIA INC (MTVA:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for METAVIA INC (MTVA:NASDAQ)?
The most recent sentiment for METAVIA INC (MTVA:NASDAQ) is .
SEC-8K** Filing Available For METAVIA INC (MTVA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.